<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Dianthus Therapeutics Stock Earns RS Rating Upgrade</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Dianthus Therapeutics Stock Earns RS Rating Upgrade</h1>
  <ul>
<li>IBD's unique rating identifies share price movement with a 1 (worst) to 99 (best) score.</li>
<li>On Monday, Dianthus Therapeutics stock hit an important technical milestone, with its Relative Strength (RS) Rating climbing into the 80-plus percentile with an upgrade to 81, an increase from 74 the day before.</li>
<li>Is Dianthus Therapeutics Stock A Buy?</li>
</ul>
<p><a href="https://finance.yahoo.com/m/f2e22761-349e-3b0b-82bf-d9201c37cda0/dianthus-therapeutics-stock.html">Source</a> · 2025-09-08T18:45:20+00:00</p>
</body>
</html>